For example, tissue factor‐factor VIIa signaling through protease‐activated receptor 2 (PAR2) in tumors was recently shown to upregulate PD‐L1 expression and shield breast cancer cells from CD8+ T cell attack [48]. This evidence concerns the gene CD274 and breast cancer.